The University of Chicago Header Logo

Connection

Mark Talamonti to Interleukin-23

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Interleukin-23.
Mark Talamonti
Connection Strength
0.108
Interleukin-23
  1. Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol. 2013 Aug; 169(2):458-63.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.